Tomer Kariv
InvestorInvestor at Pontifax Venture Capital · Board director at Imel BioTherapeutics
Tel Aviv, Israel
Writes $10M – $50M checks · typically $25M
Find your path to Tomer
11 people in our graph share verified history with Tomer — schools, employers, funds. One of them is your warm intro.
About
Co-founder and CEO of Pontifax, focused on strategic planning and serving on many portfolio company boards including Keros Therapeutics, Ocon Healthcare, ARMGO, Abcuro, and V-Wave. Previously held senior roles at leading Israeli financial institutions. Holds a B.A. in Economics and a J.D. from Harvard.
Contact· self-published, not guessed
Board director at Imel BioTherapeutics
Intro paths
In turn, Tomer can intro founders to Imel BioTherapeutics's investors below.
Imel BioTherapeutics's investors · 2
Deals · 1
AbcuroBoard seat
via Pontifax Venture Capital · filed Aug 2023 · $199.5M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Per SEC Form D filings.
Colleagues at Pontifax Venture Capital
Frequently asked questions
- Who is Tomer Kariv?
- Co-founder and CEO of Pontifax, focused on strategic planning and serving on many portfolio company boards including Keros Therapeutics, Ocon Healthcare, ARMGO, Abcuro, and V-Wave. Previously held senior roles at leading Israeli financial institutions. Holds a B.A. in Economics and a J.D. from Harvard.
- Where does Tomer Kariv work?
- Tomer Kariv is Investor at Pontifax Venture Capital and Board director at Imel BioTherapeutics.
- What check size does Tomer Kariv write?
- Tomer Kariv typically writes checks of $10M – $50M.
- What boards does Tomer Kariv sit on?
- Tomer Kariv holds tracked board seats at Abcuro, Imel BioTherapeutics.